Search research articles
Contact Us
Filters
Showing results (61-70 of 246) with videos related to
Page
of 25
Sort By:
European Journal of Clinical Pharmacology
|
September 1, 1979
Defective N-oxidation of sparteine in man: a new pharmacogenetic defect
M Eichelbaum, N Spannbrucker, B Steincke, et al.
Journal of Pharmacokinetics and Biopharmaceutics
|
August 1, 1978
Absorption of oral tetracycline in patients with Billroth-II gastrectomy
H R Ochs, D J Greenblatt, H J Dengler
American Journal of Hematology
|
September 2, 2006
Suspected cardiac amyloidosis: endomyocardial biopsy remains the diagnostic gold-standard
Arnt V Kristen, Thomas J Dengler, Hugo A Katus
Schweizerische Medizinische Wochenschrift
|
May 14, 1977
[Clinical study of the biological availability of lanatoside C and digoxin in long-term tests]
G Bodem, H Ochs, E Hahn, et al.
Biomedical Mass Spectrometry
|
October 1, 1977
Metabolism of DL-[14C]prenylamine in man
G Remberg, M Eichelbaum, G Spiteller, et al.
Archives Internationales De Pharmacodynamie Et De Therapie
|
March 1, 1974
Pharmacokinetics and metabolism of alpha-acetyldigoxin in man
G Bodem, K Wirth, E Gernand, et al.
European Journal of Clinical Pharmacology
|
January 1, 1997
Polymorphic CYP2D6 mediates O-demethylation of the opioid analgesic tramadol
W D Paar, S Poche, J Gerloff, et al.
Der Anaesthesist
|
June 1, 1975
Pharmacokinetics of ketamine in man
J Wieber, R Gugler, J H Hengstmann, et al.
Clinical and Experimental Immunology
|
May 1, 1994
Defective CD2 T cell pathway activation in common variable immunodeficiency (CVID)
S Zielen, T J Dengler, P Bauscher, et al.
European Journal of Clinical Pharmacology
|
February 1, 1980
Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquine
L Bertilsson, H J Dengler, M Eichelbaum, et al.
Page
of 25
Search research articles
Search
Showing results (61-70 of 246) with videos related to
Sort By:
Page
of 25
European Journal of Clinical Pharmacology
|
September 1, 1979
Defective N-oxidation of sparteine in man: a new pharmacogenetic defect
M Eichelbaum, N Spannbrucker, B Steincke, et al.
Journal of Pharmacokinetics and Biopharmaceutics
|
August 1, 1978
Absorption of oral tetracycline in patients with Billroth-II gastrectomy
H R Ochs, D J Greenblatt, H J Dengler
American Journal of Hematology
|
September 2, 2006
Suspected cardiac amyloidosis: endomyocardial biopsy remains the diagnostic gold-standard
Arnt V Kristen, Thomas J Dengler, Hugo A Katus
Schweizerische Medizinische Wochenschrift
|
May 14, 1977
[Clinical study of the biological availability of lanatoside C and digoxin in long-term tests]
G Bodem, H Ochs, E Hahn, et al.
Biomedical Mass Spectrometry
|
October 1, 1977
Metabolism of DL-[14C]prenylamine in man
G Remberg, M Eichelbaum, G Spiteller, et al.
Archives Internationales De Pharmacodynamie Et De Therapie
|
March 1, 1974
Pharmacokinetics and metabolism of alpha-acetyldigoxin in man
G Bodem, K Wirth, E Gernand, et al.
European Journal of Clinical Pharmacology
|
January 1, 1997
Polymorphic CYP2D6 mediates O-demethylation of the opioid analgesic tramadol
W D Paar, S Poche, J Gerloff, et al.
Der Anaesthesist
|
June 1, 1975
Pharmacokinetics of ketamine in man
J Wieber, R Gugler, J H Hengstmann, et al.
Clinical and Experimental Immunology
|
May 1, 1994
Defective CD2 T cell pathway activation in common variable immunodeficiency (CVID)
S Zielen, T J Dengler, P Bauscher, et al.
European Journal of Clinical Pharmacology
|
February 1, 1980
Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquine
L Bertilsson, H J Dengler, M Eichelbaum, et al.
Page
of 25